drugset
drugset / Trial / NCT02630069

CDP-choline Treatment in ATS Users

NCT02630069 ↗

Phase 2 Unknown 160 enrolled Ewha Womans University Mokdong Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a 12-week, randomized, double-blind, placebo-controlled trial of cytidine-5'-diphosphate choline in amphetamine-type stimulants-using adolescents.

Timeline

Start
2015-03
Primary completion
2022-12
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Citicoline Other / unclassified 500 mg —

Indications

substance-related disorder